Reduction of phenol-imine derivatives RЈN=CH(3,5-R 2 C 6 H 2 -2-OH) (R = tBu; RЈ = C 6 H 5 1a, p-MeC 6 H 4 1b, Cy 1c, tBu 1d, 2,6-Me 2 C 6 H 3 1e; R = H; RЈ = p-MeC 6 H 4 1f; Cy = cyclohexyl) with MBH 4 (M = Li, Na) or AlLiH 4 in ethyl ether or thf at room temperature affords the phenol-amine compounds RЈNHCH 2 (3,5-R 2 C 6 H 2 -2-OH) 2a-c and 2e,f. The N-R- [2,4-ditert-butyl]benzo-1-oxa-3-azine species (R = tBu 2d1, 2,6-Me 2 C 6 H 3 2e1) are obtained by Mannich reaction of 2,4-ditert-butylphenol with RNH 2 in refluxing methanol. Intermediate 2d1 is converted in ethanol at room temperature into N-tert-butyl [2-hydroxy-3,5-di-tert-butyl]benzylamine (2d), whereas 2e is not obtained from 2e1 by using this procedure.
N-alkyl,N-tert-butyl[2-hydroxy-3,5-di-tert-butyl]benzylamine compounds tBuN(R)CH
Two diiminobis(phenolate) zirconium complexes [C6H10-{NCH-(3,5-
t
Bu2C6H2-2-O)-κO}2]ZrX2 [X = CH2Ph (1), Cl (3)] have been synthesized and characterized by NMR solution spectroscopy.
Complex 1 was found conformationally stable and isolated in the octahedral C
2 symmetric form. When
exposed to the light in hydrocarbon solution, 1 readily undergoes to 1,2 benzyl migration converting the
diiminobis(phenolate) ligand in the corresponding benzylamidoiminobis(phenolate). Complex 3 is more
thermally stable and found in slow equilibrium between the cis-α and cis-β forms with the former largely
prevalent (9:1 molar ratio). The rate of interconversion between the two diastereoisomers was estimated
in 3.6 × 10-1 s-1 by NMR exchange spectroscopy (EXSY). 1 and 3 are active ethylene polymerization
catalysts after reaction with MAO or [CPh3][B(C6F5)4]/Al-
i
Bu3. The polydispersity index of polyethylene
produced by 1 is about 2, suggesting the presence of a single active species and that the symmetry of the
precatalyst is retained during polymerization. The catalyst is stable over 3 h, and the polymerization
activity linearly increases with time. Copolymers of ethylene with propylene or 1-hexene were synthesized,
and the 13C NMR analysis of their microstructure suggested the highly regioregular 1,2 insertion of the
1-olefin and the inability of the ligand environment to express stereochemical control during monomer
insertion.
The Schiff base N,N
‘-o-phenylenebis(3,5-di-tert-butyl-salicylideneimine) (1;
t
Bu4salophenH2)
reacts with 1 equiv of Zr(η5-C5H5)Cl3·DME in the presence of 2.2 equiv of NEt3 in pentane
to give the monocyclopentadienyl bis(phenoxo-imino) monochloro zirconium derivative Zr(η5-C5H5)[C6H4-1,2-{NCH(3,5-
t
Bu2C6H2-2-O)}2]Cl (2). Moreover, 2 equiv of the monolithiated
reagent derived from 3-tert-butyl-N-ethylsalicylaldimine by reaction with Li
n
Bu in hexane
reacts at −78 °C with 1 equiv of Zr(η5-C5H5)Cl3·DME in THF to yield the corresponding
monocyclopentadienyl bis(phenoxo-imino) monochloro zirconium complex Zr(η5-C5H5)[CH3CH2NCH{(3-
t
BuC6H3-2-O)}]2Cl (5) after elimination of LiCl. Methylation of 2 with MgClMe
in pentane or toluene at −78 °C affords Zr(η5-C5H5)[1,2-C6H4{NCH(3,5-
t
Bu2C6H2-2-O)}{NCH(Me)(3,5-
t
Bu2C6H2-2-O)}] (3) as a result of the reduction of one of the CN bonds of
the coligand. The hydrolysis of 3 gives the new organic compound [C6H4{NCH(3,5-
t
Bu2C6H2-2-OH)}{NCH(Me)(3,5-
t
Bu2C6H2-2-OH)}] (4), which was also quantitatively isolated by
reaction of 1 with MgClMe followed by treatment with a saturated solution of NH4Cl in
water. All of the reported compounds were characterized by the usual analytical and
spectroscopic methods, and the molecular structure of 5 was determined by X-ray diffraction
analysis from suitable single crystals. The catalytic activities of 2, 3, and 5 for ethylene
polymerization using MAO as cocatalyst were determined.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.